BioNexus Gene Lab (BGLC) Total Non-Current Liabilities (2018 - 2026)
BioNexus Gene Lab recorded quarterly Total Non-Current Liabilities of $150407.0 in Q1 2026, up 28.66% quarter-over-quarter from $116899.0 in Q4 2025, and up 1.67% year-over-year from $147940.0 in Q1 2025.
BioNexus Gene Lab's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $150407.0 for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 1.67% year-over-year to $150407.0; the TTM figure through Mar 2026 stood at $150407.0 (up 1.67% YoY), while the FY2025 annual figure was $116899.0, down 26.82% from the prior year.
- Total Non-Current Liabilities came in at $150407.0 for Q1 2026 at BioNexus Gene Lab, up from $116899.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $194615.0 in Q2 2024 to a low of $39659.0 in Q3 2022.
- A 5-year average of $112847.9 and a median of $116899.0 in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities jumped 237.24% in 2023 and plunged 33.89% in 2025, its largest moves.
- BioNexus Gene Lab's Total Non-Current Liabilities stood at $71072.0 in 2022, then surged by 56.2% to $111018.0 in 2023, then surged by 43.89% to $159741.0 in 2024, then slipped by 26.82% to $116899.0 in 2025, then increased by 28.66% to $150407.0 in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $150407.0, $116899.0, and $126943.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 35.25 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 5.04 Bn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 19.36 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 14.37 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 19.98 Bn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 13.25 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 22.22 Bn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 3.91 Bn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 6.03 Bn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 150,407.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,407.00 |
| Dec 31, 2025 | 116,899.00 |
| Sep 30, 2025 | 126,943.00 |
| Jun 30, 2025 | 141,347.00 |
| Mar 31, 2025 | 147,940.00 |
| Dec 31, 2024 | 159,741.00 |
| Sep 30, 2024 | 192,013.00 |
| Jun 30, 2024 | 194,615.00 |
| Mar 31, 2024 | 100,762.00 |
| Dec 31, 2023 | 111,018.00 |
| Sep 30, 2023 | 133,747.00 |
| Jun 30, 2023 | 58,705.00 |
| Mar 31, 2023 | 66,354.00 |
| Dec 31, 2022 | 71,072.00 |
| Sep 30, 2022 | 39,659.00 |
| Jun 30, 2022 | 44,542.00 |
| Mar 31, 2022 | 62,650.00 |
| Dec 31, 2021 | 65,856.00 |
| Sep 30, 2021 | 48,575.00 |
| Jun 30, 2021 | 59,106.00 |
| Mar 31, 2021 | 70,672.00 |
| Dec 31, 2020 | 79,541.00 |
| Sep 30, 2020 | 43,466.00 |
| Jun 30, 2020 | 44,106.00 |
| Mar 31, 2020 | 46,826.00 |
| Dec 31, 2019 | 57,298.00 |
| Dec 31, 2018 | 67,420.00 |